185 related articles for article (PubMed ID: 37330661)
21. Circadian mRNA expression of coagulation and fibrinolytic factors is organ-dependently disrupted in aged mice.
Oishi K; Koyanagi S; Ohkura N
Exp Gerontol; 2011 Dec; 46(12):994-9. PubMed ID: 21963655
[TBL] [Abstract][Full Text] [Related]
22. Involvement of circadian clock gene Clock in diabetes-induced circadian augmentation of plasminogen activator inhibitor-1 (PAI-1) expression in the mouse heart.
Oishi K; Ohkura N; Amagai N; Ishida N
FEBS Lett; 2005 Jul; 579(17):3555-9. PubMed ID: 15950223
[TBL] [Abstract][Full Text] [Related]
23. TRPM7 restrains plasmin activity and promotes transforming growth factor-β1 signaling in primary human lung fibroblasts.
Zeitlmayr S; Zierler S; Staab-Weijnitz CA; Dietrich A; Geiger F; Horgen FD; Gudermann T; Breit A
Arch Toxicol; 2022 Oct; 96(10):2767-2783. PubMed ID: 35864199
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2.
Schoenhard JA; Smith LH; Painter CA; Eren M; Johnson CH; Vaughan DE
J Mol Cell Cardiol; 2003 May; 35(5):473-81. PubMed ID: 12738229
[TBL] [Abstract][Full Text] [Related]
25. Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression.
Ohkura N; Oishi K; Fukushima N; Kasamatsu M; Atsumi GI; Ishida N; Horie S; Matsuda J
J Thromb Haemost; 2006 Nov; 4(11):2478-85. PubMed ID: 16970803
[TBL] [Abstract][Full Text] [Related]
26. Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
Oishi K
Clin Exp Hypertens; 2009 May; 31(3):208-19. PubMed ID: 19387897
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
[TBL] [Abstract][Full Text] [Related]
28. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB
J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
[TBL] [Abstract][Full Text] [Related]
30. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
[TBL] [Abstract][Full Text] [Related]
31. Urokinase plasminogen activator induces epithelial-mesenchymal and metastasis of pancreatic cancer through plasmin/MMP14/TGF-β axis, which is inhibited by 4-acetyl-antroquinonol B treatment.
Wu CZ; Chu YC; Lai SW; Hsieh MS; Yadav VK; Fong IH; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen JS
Phytomedicine; 2022 Jun; 100():154062. PubMed ID: 35366491
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta signaling leads to uPA/PAI-1 activation and metastasis: a study on human breast cancer tissues.
Lang DS; Marwitz S; Heilenkötter U; Schumm W; Behrens O; Simon R; Reck M; Vollmer E; Goldmann T
Pathol Oncol Res; 2014 Jul; 20(3):727-32. PubMed ID: 24610082
[TBL] [Abstract][Full Text] [Related]
33. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
[TBL] [Abstract][Full Text] [Related]
34. Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals.
Zhang G; Kernan KA; Collins SJ; Cai X; López-Guisa JM; Degen JL; Shvil Y; Eddy AA
J Am Soc Nephrol; 2007 Mar; 18(3):846-59. PubMed ID: 17267741
[TBL] [Abstract][Full Text] [Related]
35. Proxisome proliferator-activated receptor-α mediates high-fat, diet-enhanced daily oscillation of plasminogen activator inhibitor-1 activity in mice.
Hayashida S; Kuramoto Y; Koyanagi S; Oishi K; Fujiki J; Matsunaga N; Ikeda E; Ohdo S; Shimeno H; Soeda S
Chronobiol Int; 2010 Oct; 27(9-10):1735-53. PubMed ID: 20969520
[TBL] [Abstract][Full Text] [Related]
36. Plasmin is not protective in experimental renal interstitial fibrosis.
Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR
Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
[TBL] [Abstract][Full Text] [Related]
37. Deficiency of Bmal1 disrupts the diurnal rhythm of haemostasis.
Hemmeryckx B; Frederix L; Lijnen HR
Exp Gerontol; 2019 Apr; 118():1-8. PubMed ID: 30610898
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia.
Docagne F; Nicole O; Marti HH; MacKenzie ET; Buisson A; Vivien D
FASEB J; 1999 Aug; 13(11):1315-24. PubMed ID: 10428756
[TBL] [Abstract][Full Text] [Related]
39. The significance of colocalization of plasminogen activator inhibitor-1 and vitronectin in hepatic fibrosis.
Inuzuka S; Ueno T; Torimura T; Tamaki S; Sugawara H; Sakata R; Kusaba N; Sata M; Tanikawa K
Scand J Gastroenterol; 1997 Oct; 32(10):1052-60. PubMed ID: 9361180
[TBL] [Abstract][Full Text] [Related]
40. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
